What is Bodd?
Bodd operates at the intersection of advanced hardware and data analytics, providing sophisticated 3D body scanning technology designed for both commercial and healthcare applications. By capturing precise human body measurements and structural data, the company enables businesses to offer personalized experiences and clinical-grade insights. Its market position is defined by the ability to translate physical human dimensions into actionable digital intelligence, serving a diverse clientele that requires high-accuracy biometric inputs for product development and health monitoring.
The company's technological stack facilitates seamless integration into existing retail and medical workflows, effectively bridging the gap between physical presence and digital utility. As industries increasingly prioritize data-driven personalization, Bodd remains a critical infrastructure provider for organizations seeking to optimize their service delivery through accurate, non-invasive body mapping.
How much funding has Bodd raised?
Bodd has raised a total of $14.9M across 2 funding rounds:
Other Financing Round
$5M
Other Financing Round
$9.9M
Other Financing Round (2022): $5M with participation from Tim Allison, Nick Hirons, and Candace Hirons
Other Financing Round (2025): $9.9M led by Blue Sky Capital and Ellerston Capital
Key Investors in Bodd
Blue Sky Capital
Blue Sky Capital Corporation is a private investment firm that focuses on high-potential teams, technologies, and business models, particularly in mobile and security-related technologies for the financial services and payment sectors.
Ellerston Capital
Ellerston Capital is a specialist investment management firm providing innovative equity and alternative investment strategies, serving institutional and retail clients across global markets with a focus on the Oceania region.
Tim Allison
An individual investor participating in the funding round to support the company's strategic growth and technological development.
What's next for Bodd?
With the recent infusion of capital, Bodd is set to embark on an aggressive phase of international expansion and product iteration. The strategic focus will likely center on scaling its scanning hardware deployment across global markets while enhancing the software layer that processes complex biometric datasets. By prioritizing R&D, the company aims to solidify its competitive advantage in the digital health and retail sectors, ensuring that its 3D scanning solutions remain at the forefront of the industry. Future growth will be contingent upon the successful integration of its technology into large-scale enterprise ecosystems, further cementing its role as a leader in the human-centric data economy.
See full Bodd company page
